Bavarian Nordic A/S (CPH:BAVA)
197.00
+3.40 (1.76%)
May 19, 2026, 12:15 PM CET
Bavarian Nordic Revenue
Bavarian Nordic had revenue of 1.06B DKK in the quarter ending March 31, 2026, a decrease of -21.44%. This brings the company's revenue in the last twelve months to 5.96B, down -4.43% year-over-year. In the year 2025, Bavarian Nordic had annual revenue of 6.24B with 9.23% growth.
Revenue (ttm)
5.96B
Revenue Growth
-4.43%
P/S Ratio
2.49
Revenue / Employee
3.20M
Employees
1,861
Market Cap
14.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.24B | 527.75M | 9.23% |
| Dec 31, 2024 | 5.72B | -1.35B | -19.06% |
| Dec 31, 2023 | 7.06B | 3.91B | 124.14% |
| Dec 31, 2022 | 3.15B | 1.25B | 66.02% |
| Dec 31, 2021 | 1.90B | 45.49M | 2.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 327.80B |
| Coloplast | 28.05B |
| H. Lundbeck | 25.52B |
| Genmab | 25.29B |
| GN Store Nord | 16.60B |
| Zealand Pharma | 9.24B |
| ALK-Abelló | 6.56B |
| Embla Medical | 6.21B |
Bavarian Nordic News
- 5 days ago - Bavarian Nordic AS (BVNKF) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 5 days ago - Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such - GlobeNewsWire
- 5 days ago - Bavarian Nordic Earnings Call Transcript: Q1 2026 - Transcripts
- 5 days ago - Bavarian Nordic Quarterly report: Q1 2026 - Filings
- 5 days ago - Bavarian Nordic Slides: Q1 2026 - Filings
- 6 days ago - Bavarian Nordic Announces Interim Results for the First Three Months of 2026 - GlobeNewsWire
- 7 days ago - Bavarian Nordic Raises 2026 Guidance After Additional U.S. Vaccine Order - Nasdaq
- 7 days ago - Denmark's Bavarian Nordic raises 2026 forecast - Reuters